Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Roche Wins Two French Early Access Programs In Breast Cancer

Aug 28 2019

• By Ian Schofield

Approved — France has OKd early access for new, unapproved uses of two cancer drugs

Related Content

Keeping Track: US FDA Approves Sanofi’s Dengvaxia, But Heron’s HTX-011 And Nabriva’s Contepo Fall Short

May 06 2019

France OKs Early Access To Tecentriq For SCLC Pending EU Approval

May 09 2019

Keeping Track: Accelerated Approval For Tecentriq And A Burst Of Filings And Submissions

Mar 11 2019

European CHMP Opinions and MAA Updates

Jul 02 2019

Related Companies

AstraZeneca PLC

Merck & Co., Inc.

Additional Topics

France Europe Market Access Regulation Cancer BioPharmaceutical

More from France

More from Europe

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window